- Home
- / EXACT Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
EXACT Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€0.5
2024-10-29
Market Capitalization
€15.6 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| NOK | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.6M | 7.4M | ||||||
| Gross profit | 5.6M | 7.4M | 52.0K | 455.0K | 4.0K | 59.0K | ||
| Gross profit margin, % | 100.0% | 100.0% | ||||||
| Operating expense total | 13.1M | 23.1M | 33.6M | 57.3M | 39.2M | 46.3M | 50.4M | 81.3M |
| Depreciation and amortization | 126.0K | 284.0K | 1.1M | 1.8M | 2.0M | 2.1M | 2.4M | 3.7M |
| EBITDA | (7.5M) | (15.7M) | (33.6M) | (57.3M) | (38.8M) | (46.3M) | (50.4M) | (81.2M) |
| EBITDA margin, % | -134.4% | -211.3% | ||||||
| EBIT | (7.6M) | (16.0M) | (34.7M) | (59.1M) | (40.8M) | (48.4M) | (52.9M) | (84.9M) |
| EBIT margin, % | -136.6% | -215.1% | ||||||
| Interest income | 65.0K | 340.0K | 479.0K | 945.0K | 925.0K | 2.6M | ||
| Interest expense | 7.0K | 72.0K | 24.0K | 103.0K | 501.0K | 86.0K | 65.0K | 39.0K |
| Pre tax profit | (7.6M) | (15.0M) | (33.1M) | (58.6M) | (40.6M) | (48.4M) | (52.3M) | (87.0M) |
| Income tax expense | (462.0K) | (48.0K) | ||||||
| Net Income | (7.6M) | (15.0M) | (33.1M) | (58.6M) | (40.1M) | (48.3M) | (52.3M) | (87.0M) |